Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
07/05/2006 | EP1569909B1 Substituted pyrazoline carboxanilides for use as pesticides |
07/05/2006 | EP1225894B1 Fab i inhibitors |
07/05/2006 | CN1798748A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
07/05/2006 | CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren |
07/05/2006 | CN1798739A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
07/05/2006 | CN1798738A Biaryl substituted pyrazoles as sodium channel blockers |
07/05/2006 | CN1796372A Antibacterial compound A-45, and application in preparing antibacterial drug |
07/05/2006 | CN1796371A Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof |
07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
07/04/2006 | US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
07/04/2006 | US7070626 Oxidative coloring agents for keratin fibers |
06/29/2006 | WO2006068591A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
06/29/2006 | WO2006067472A1 Parp inhibitors |
06/29/2006 | WO2006067443A1 Therapeutic agents |
06/29/2006 | WO2006066790A1 Tetralin and indane derivatives and uses thereof |
06/29/2006 | WO2006066779A1 Novel cyclohexane derivatives |
06/29/2006 | US20060142612 Arylsulfonamide derivatives |
06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
06/29/2006 | US20060142589 Process for obtaining enantiomers of Cizolirtine |
06/29/2006 | US20060142367 Pyrazole compound |
06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
06/29/2006 | US20060142284 Cyclin dependent kinases (CDK2) inhibitors; 4-[5-(3-bromo-phenyl)-2H-pyrazol-3-ylamino]-benzenesulfonamide; cancer and hyperproliferative diseases, such as psoriasis |
06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
06/29/2006 | CA2591937A1 Tetralin and indane derivatives and uses thereof |
06/29/2006 | CA2589827A1 Mitotic kinesin inhibitors |
06/29/2006 | CA2589648A1 Fused pyrazole derivatives and methods of treatment of metabolic-relateddisorders thereof |
06/28/2006 | EP1674458A1 Process for obtaining enantiomers of cizolirtine |
06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
06/28/2006 | EP1301829A4 Radiation sensitive compositions containing image quality and profile enhancement additives |
06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
06/27/2006 | US7067548 Non-emetic 1-phenyl- or pyridyl-pyrazoles. |
06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
06/22/2006 | WO2006066126A2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
06/22/2006 | WO2006064957A1 Amide compound and thrombopoietin receptor activator |
06/22/2006 | WO2006063861A1 Process for obtaining cizolirtine and its enantiomers |
06/22/2006 | WO2006063700A1 1-arylpyrazoles and their use as pesticides |
06/22/2006 | WO2006048761A3 Methods for preparing indazole compounds |
06/22/2006 | WO2006044359A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
06/22/2006 | US20060135788 Process for obtaining cizolirtine and its enantiomers |
06/22/2006 | US20060135778 Pesticidal 5-(acylamino) pyrazole derivatives |
06/22/2006 | US20060135776 4-Cyanopyrazole-3-carboxamide derivatives, preparation, and application thereof |
06/22/2006 | US20060135770 PARP inhibitors |
06/22/2006 | US20060135589 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors |
06/22/2006 | US20060135588 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
06/22/2006 | US20060134539 Pyrazolone-substituted cyclyhexadienones; can be dispersed in a photosensitive layer at a high concentration and has a high electron mobility |
06/22/2006 | CA2587423A1 1-arylpyrazoles and their use as pesticides |
06/21/2006 | EP1671967A1 1-Arylpyrazoles and their use as pesticides |
06/21/2006 | EP1671953A1 Process for obtaining cizolirtine and its enantiomers |
06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
06/21/2006 | EP1671941A1 Substituted benzanilide compound and pest control agent |
06/21/2006 | EP1670787A2 Cytokine inhibitors |
06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
06/21/2006 | EP1670757A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
06/21/2006 | EP1670756A1 Heterocyclyl compounds |
06/21/2006 | EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
06/21/2006 | EP1670460A2 Pyrazole derivatives as cannabinoid receptor modulators |
06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
06/21/2006 | EP1362049B1 Pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres |
06/21/2006 | EP1146037B1 Process for the preparation of optically active amino alcohols |
06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
06/21/2006 | CN1791582A Iodopyrazolyl carboxanilides. |
06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
06/21/2006 | CN1260218C PDF enzyme inhibitor-hydroxamic acid serial compounds, synthetic method and use thereof |
06/21/2006 | CN1260216C Method for synthesizing 1-methyl-benzdiazole-3-formic acid |
06/21/2006 | CN1260215C Antagon of endostadin receptor pyrazole carboxylic acids |
06/20/2006 | US7064124 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example |
06/20/2006 | US7063928 An apparatus having an organophotoreceptor in the form of a flexible belt threaded around support rollers and having a charge transfer compound comprising a fluorenone hydrazone including other functional groups and phenyl and heteraryl rings;used with liquid toner; durability |
06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
06/15/2006 | WO2006062978A1 Method for preparing n-phenylpyrazole-1-carboxamides |
06/15/2006 | WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
06/15/2006 | WO2006062240A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
06/15/2006 | WO2006062224A1 Carboxamide derivative |
06/15/2006 | WO2006062097A1 Agent for prevention and/or treatment of pruritus |
06/15/2006 | WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides |
06/15/2006 | WO2006061147A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof |
06/15/2006 | WO2006061146A1 5-aminopyrazole derivatives as pesticidal compounds |
06/15/2006 | WO2006061074A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
06/15/2006 | WO2006044379A3 Novel curcumin analogues and uses thereof |
06/15/2006 | WO2006015860A3 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
06/15/2006 | US20060128965 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid |
06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
06/15/2006 | US20060128811 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine |
06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
06/15/2006 | US20060128685 Pyrazole derivative |
06/15/2006 | US20060128635 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
06/15/2006 | US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors |
06/15/2006 | CA2590962A1 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
06/15/2006 | CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
06/15/2006 | CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides |